Munich - Delayed Quote EUR
SELLAS Life Sciences Group Inc (RXK3.MU)
1.4940
-0.0410
(-2.67%)
At close: May 30 at 5:25:50 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
19,432
6,219
20,943
26,275
Total Liabilities Net Minority Interest
9,967
14,195
16,092
5,928
Total Equity Gross Minority Interest
9,465
-7,976
4,851
20,347
Total Capitalization
9,465
-7,976
4,851
20,347
Common Stock Equity
9,465
-7,976
4,851
20,347
Capital Lease Obligations
1,001
906
945
808
Net Tangible Assets
7,551
-9,890
2,937
18,433
Working Capital
6,817
-10,563
2,241
18,062
Invested Capital
9,465
-7,976
4,851
20,347
Tangible Book Value
7,551
-9,890
2,937
18,433
Total Debt
1,001
906
945
808
Share Issued
73,977.4590
32,132.8900
21,005.4050
15,895.6370
Ordinary Shares Number
73,977.4590
32,132.8900
21,005.4050
15,895.6370
12/31/2021 - 12/14/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
600161.SS TIANTAN BIO
19.13
-0.52%
25I.SG ImmuPharma PLC
0.0210
-20.75%
GXE.F Galapagos NV
25.16
-1.02%
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
NANOFS.ST Nanoform Finland Oyj
9.98
-1.38%
22Z.SG Zealand Pharma A/S
60.78
+0.10%
8GN.F Cessatech A/S
1.6700
0.00%
FTD.SG Financière de Tubize SA
125.40
+1.29%
BCX.WA Bioceltix S.A.
103.80
-4.07%
NVV1.BE Novavax Inc
6.33
+0.91%